<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02631525</url>
  </required_header>
  <id_info>
    <org_study_id>CAAE - 31820014.8.0000.5149</org_study_id>
    <nct_id>NCT02631525</nct_id>
  </id_info>
  <brief_title>Recovery Profile Comparison Between Remifentanil-propofol or Desflurane Anesthesia Monitored With Bispectral Index.</brief_title>
  <official_title>A Comparison of Post-operative Recovery Between Remifentanil-propofol and Remifentanil-desflurane Anesthesia Guided by Bispectral Index Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Minas Gerais</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal University of Minas Gerais</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bispectral monitoring anesthesia with remifentanil-desflurane has a better post-operative&#xD;
      recovery than remifentanil-propofol.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is a randomized, double blind study, involving 40 adult female patients submitted to&#xD;
      general anesthesia. The patients were distributed into 2 groups: remifentanil-propofol-based&#xD;
      anesthesia and remifentanil-desflurane-based anesthesia groups. Bispectral index (BIS)&#xD;
      monitoring guided the anesthesia by setting target BIS range value between 40 and 60.&#xD;
      Anesthetics were adjusted to reached that. Primary outcome was: extubation time (time from&#xD;
      anesthetic discontinuation to endotracheal tube cuff). Secondary measured outcomes:&#xD;
      intra-operative cardiovascular drug use; time to follow command before extubation; protective&#xD;
      airway reflex recovery time after extubation. Protective airway reflex test recovery was&#xD;
      performed at predetermined time intervals (2, 6, 14, 22 and 30 minutes) from the time to&#xD;
      follow a standard command until the first demonstrated ability to swallow 20 ml of water in&#xD;
      an upright position.Post-anesthesia care unit recovery data were also recorded: Ramsay&#xD;
      sedation scale; vital signs, post-operative pain; morphine consumption.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Extubation Time</measure>
    <time_frame>Time from anesthetic discontinuation to endotracheal tube cuff deflation</time_frame>
    <description>Time from anesthetic discontinuation to endotracheal tube cuff deflation</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Delayed Emergence From Anesthesia</condition>
  <arm_group>
    <arm_group_label>REM-PRO</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Total intravenous anesthesia with remifentanil and propofol, target controlled infusion based on Minto's and Marsh's pharmacokinetic models.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>REM-DES</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Balanced anesthesia with remifentanil target controlled infusion based on Minto's pharmacokinetic model and desflurane.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desflurane</intervention_name>
    <description>Balanced anesthesia with remifentanil and desflurane guided by bispectral monitoring</description>
    <arm_group_label>REM-DES</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Total intravenous anesthesia based on propofol</description>
    <arm_group_label>REM-PRO</arm_group_label>
    <other_name>Diprivan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female patients over 18 years old classified by the American Society of&#xD;
             Anesthesiologists as physical status I or II, undergoing elective breast surgery with&#xD;
             general anesthesia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of: illegal drug and alcohol abuse&#xD;
&#xD;
          -  Pregnancy on course or suspicion of&#xD;
&#xD;
          -  Neuromuscular disorders&#xD;
&#xD;
          -  Cerebral vascular disease&#xD;
&#xD;
          -  Dysphagia&#xD;
&#xD;
          -  Dysphonia&#xD;
&#xD;
          -  Gastroesophageal reflux disease&#xD;
&#xD;
          -  Previous larynx and/or upper gastrointestinal tract surgery&#xD;
&#xD;
          -  Allergy to any drug to be used and malignant hyperthermia.&#xD;
&#xD;
          -  Patients who develop hemodynamic instability in the surgery and need blood transfusion&#xD;
             were excluded from the study.&#xD;
&#xD;
          -  Patients unable to swallow 20 ml of water in an upright position were also excluded.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Renato S Gomez, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor of the Medicine School of the Federal University of Minas Gerais</affiliation>
  </overall_official>
  <reference>
    <citation>Wu ZF, Jian GS, Lee MS, Lin C, Chen YF, Chen YW, Huang YS, Cherng CH, Lu CH. An analysis of anesthesia-controlled operating room time after propofol-based total intravenous anesthesia compared with desflurane anesthesia in ophthalmic surgery: a retrospective study. Anesth Analg. 2014 Dec;119(6):1393-406. doi: 10.1213/ANE.0000000000000435.</citation>
    <PMID>25211391</PMID>
  </reference>
  <reference>
    <citation>Mckay RE, Large MJC, Balea MC, Mckay WR. Airway reflexes return more rapidly after desflurane anesthesia than after sevoflurane anesthesia. Anesth Analg. 2005 Mar;100(3):697-700. doi: 10.1213/01.ANE.0000146514.65070.AE.</citation>
    <PMID>15728054</PMID>
  </reference>
  <reference>
    <citation>Wachtel RE, Dexter F, Epstein RH, Ledolter J. Meta-analysis of desflurane and propofol average times and variability in times to extubation and following commands. Can J Anaesth. 2011 Aug;58(8):714-24. doi: 10.1007/s12630-011-9519-1. Epub 2011 Jun 1.</citation>
    <PMID>21630118</PMID>
  </reference>
  <reference>
    <citation>Punjasawadwong Y, Phongchiewboon A, Bunchungmongkol N. Bispectral index for improving anaesthetic delivery and postoperative recovery. Cochrane Database Syst Rev. 2014 Jun 17;(6):CD003843. doi: 10.1002/14651858.CD003843.pub3. Review. Update in: Cochrane Database Syst Rev. 2019 Sep 26;9:CD003843.</citation>
    <PMID>24937564</PMID>
  </reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>December 4, 2015</study_first_submitted>
  <study_first_submitted_qc>December 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2015</study_first_posted>
  <results_first_submitted>August 11, 2020</results_first_submitted>
  <results_first_submitted_qc>August 11, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 25, 2020</results_first_posted>
  <last_update_submitted>August 11, 2020</last_update_submitted>
  <last_update_submitted_qc>August 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Minas Gerais</investigator_affiliation>
    <investigator_full_name>Renato Santiago Gomez</investigator_full_name>
    <investigator_title>Head of surgery department of the Medical School of the Federal University of Minas Gerais</investigator_title>
  </responsible_party>
  <keyword>Airway extubation</keyword>
  <keyword>Anesthesia Recovery Period</keyword>
  <keyword>Desflurane</keyword>
  <keyword>Propofol</keyword>
  <keyword>Intravenous anesthesia</keyword>
  <keyword>Balanced Anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delayed Emergence from Anesthesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>REM-PRO</title>
          <description>Total intravenous anesthesia with remifentanil and propofol, target controlled infusion based on Minto's and Marsh's pharmacokinetic models.&#xD;
Propofol: Total intravenous anesthesia based on propofol</description>
        </group>
        <group group_id="P2">
          <title>REM-DES</title>
          <description>Balanced anesthesia with remifentanil target controlled infusion based on Minto's pharmacokinetic model and desflurane.&#xD;
Desflurane: Balanced anesthesia with remifentanil and desflurane guided by bispectral monitoring</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>REM-PRO</title>
          <description>Total intravenous anesthesia with remifentanil and propofol, target controlled infusion based on Minto's and Marsh's pharmacokinetic models.&#xD;
Propofol: Total intravenous anesthesia based on propofol</description>
        </group>
        <group group_id="B2">
          <title>REM-DES</title>
          <description>Balanced anesthesia with remifentanil target controlled infusion based on Minto's pharmacokinetic model and desflurane.&#xD;
Desflurane: Balanced anesthesia with remifentanil and desflurane guided by bispectral monitoring</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56" spread="15"/>
                    <measurement group_id="B2" value="46" spread="11"/>
                    <measurement group_id="B3" value="50" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Brazil</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Extubation Time</title>
        <description>Time from anesthetic discontinuation to endotracheal tube cuff deflation</description>
        <time_frame>Time from anesthetic discontinuation to endotracheal tube cuff deflation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>REM-PRO</title>
            <description>Total intravenous anesthesia with remifentanil and propofol, target controlled infusion based on Minto's and Marsh's pharmacokinetic models.&#xD;
Propofol: Total intravenous anesthesia based on propofol</description>
          </group>
          <group group_id="O2">
            <title>REM-DES</title>
            <description>Balanced anesthesia with remifentanil target controlled infusion based on Minto's pharmacokinetic model and desflurane.&#xD;
Desflurane: Balanced anesthesia with remifentanil and desflurane guided by bispectral monitoring</description>
          </group>
        </group_list>
        <measure>
          <title>Extubation Time</title>
          <description>Time from anesthetic discontinuation to endotracheal tube cuff deflation</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.5" lower_limit="4.9" upper_limit="14.4"/>
                    <measurement group_id="O2" value="6.2" lower_limit="3.1" upper_limit="18.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>REM-PRO</title>
          <description>Total intravenous anesthesia with remifentanil and propofol, target controlled infusion based on Minto's and Marsh's pharmacokinetic models.&#xD;
Propofol: Total intravenous anesthesia based on propofol</description>
        </group>
        <group group_id="E2">
          <title>REM-DES</title>
          <description>Balanced anesthesia with remifentanil target controlled infusion based on Minto's pharmacokinetic model and desflurane.&#xD;
Desflurane: Balanced anesthesia with remifentanil and desflurane guided by bispectral monitoring</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Renato Gomez</name_or_title>
      <organization>Universidade federal de Minas Gerais</organization>
      <phone>553134099760</phone>
      <email>renatogomez2000@yahoo.com.br</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

